A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster.
NCT06903078
This study is recruiting at 2 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this observational research study is to study if patients with herpes zoster, also known as Shingles, have a higher risk of vascular dysfunction (problems with blood vessels, including stroke) and vascular dementia (problems with mental decline as a result of decreased blood flow to the brain) compared to patients without herpes zoster. Patients are evaluated based on the group they are assigned too: Herpes Zoster (HZ) Group: individuals presenting with untreated herpes zoster.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Herpes Zoster (HZ)
- Vascular Dementia
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Center for Clinical Studies, Texas
- Last updated on ClinicalTrials.gov
- December 11, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Texas · 2
- Center for Clinical Studies, LTD. LLP · Houston, TX
- Center for Clinical Studies, LTD. LLP · Webster, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.